Literature DB >> 7924088

Lumbar epidural lipomatosis causing neurogenic claudication in two obese patients.

W J van Rooij1, A C Borstlap, L R Canta, C C Tijssen.   

Abstract

Two obese patients suffering from neurogenic claudication caused by lumbar epidural lipomatosis are described. Although lumbar epidural lipomatosis is most often related to prolonged use of steroid drugs, obesity has also been reported as a possible cause. Both CT and MRI can demonstrate excess epidural fat; because of the possibility of sagittal views MRI is to be preferred. In one of our patient with neurogenic claudication the excess epidural fat normalised completely after considerable weight reduction and symptoms resolved. Therefore weight reduction might be the initial therapy in an obese patient with symptomatic epidural lipomatosis. When weight reduction fails or when there are urgent clinical reasons, surgical removal of the excess amount of epidural fat should be considered.

Entities:  

Mesh:

Year:  1994        PMID: 7924088     DOI: 10.1016/0303-8467(94)90059-0

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

Review 1.  Epidural lipomatosis with lumbar radiculopathy in one obese patient. Case report and review of the literature.

Authors:  R Qasho; O E Ramundo; C Maraglino; P Lunardi; G Ricci
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

Review 2.  Dorsal epidural spinal lipomatosis.

Authors:  S Chibbaro; G Mirone; M Nouri; P Di Emidio; M Polivka; M Marsella; B George
Journal:  BMJ Case Rep       Date:  2011-02-14

3.  Lumbosacral epidural lipomatosis: MRI grading.

Authors:  Daniel G Borré; Guillermo E Borré; Flavio Aude; Gladys N Palmieri
Journal:  Eur Radiol       Date:  2002-12-13       Impact factor: 5.315

4.  Multiple epidural steroid injections and body mass index linked with occurrence of epidural lipomatosis: a case series.

Authors:  Rafael Jaimes; Angelo G Rocco
Journal:  BMC Anesthesiol       Date:  2014-08-15       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.